Financial Statements — NMR
Balance Sheet
(in billions JPY)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 5,867.36 | 4,105.05 | 3,675.55 | 3,836.09 |
| Total Assets | 60,367.70 | 54,815.29 | 51,531.98 | 43,346.55 |
| Total Deposits | 3,288.09 | 2,064.28 | 2,039.01 | 1,463.65 |
| Long-term Debt | 14,407.71 | 11,442.06 | 10,094.65 | 8,695.95 |
| Total Liabilities | 56,759.04 | 51,443.05 | 48,304.68 | 40,544.92 |
| Retained Earnings | 1,975.90 | 1,642.92 | 1,608.56 | 1,557.70 |
| Total Stockholder Equity | 3,485.28 | 3,291.44 | 3,162.97 | 2,734.09 |
Income Statement
(in billions JPY) (except per-share rows)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Interest & Dividend Income | 1,302.39 | 658.46 | 196.89 | 69.93 |
| Interest Expense | 1,279.02 | 644.94 | 215.89 | 60.34 |
| Net Interest Income* | 23.37 | 13.52 | (19.00) | 9.58 |
| Provision for Credit Losses | (0.41) | 0.26 | 0.25 | (0.27) |
| Non-interest Income | 1,013.78 | 351.57 | 338.77 | 307.42 |
| Non-interest Expense | 741.85 | 311.02 | 286.47 | 300.40 |
| Pretax Income | 295.30 | 54.06 | 33.30 | 16.60 |
| Tax Provision | 93.66 | 21.15 | 14.74 | 12.98 |
| Net Income | 196.64 | 35.23 | 16.77 | 3.21 |
| Basic EPS | 66.54 | 11.61 | 5.59 | 1.04 |
| Diluted EPS | 64.53 | 11.21 | 5.41 | 1.01 |
* Derived from reported values
Cash Flow Statement
(in billions JPY)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 942.82 | 194.13 | (659.90) | (222.62) |
| Capital Expenditures | 117.19 | 52.80 | 55.97 | 51.84 |
| Free Cash Flow* | 825.63 | 141.33 | (715.86) | (274.46) |
| Investing Cash Flow | (342.20) | (332.88) | (7.76) | (5.94) |
| Financing Cash Flow | 835.38 | 223.49 | 755.43 | 548.06 |
* Derived from reported values
Dividends Per Share
(USD)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 | Q2
2013 | Q2
2012 | Q2
2011 | Q2
2010 |
|---|
| Dividends Per Share | 23.00 | 8.00 | 5.00 | 8.00 | 8.00 | 2.00 | 4.00 | 4.00 |
